Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xinxuebao Capsules (新血宝胶囊) is a Traditional Chinese Medicine (TCM) herbal formulation combined with ferrous sulfate, developed and manufactured by Chen Li Ji (Guangzhou Baiyunshan Chen Li Ji Pharmaceutical Co., Ltd.). Administered orally, it is specifically indicated for the treatment of iron-deficiency anemia, particularly cases caused by chronic blood loss (such as gastrointestinal or hemorrhoidal bleeding), excessive menstruation, pregnancy, or nutritional deficiencies. The formulation works by tonifying qi and blood and strengthening the spleen and stomach, utilizing a blend of herbs including Spatholobus suberectus, Astragalus, Chinese dates, Angelica sinensis, Atractylodes, and dried tangerine peel. The inclusion of ferrous sulfate provides a direct source of iron for hemoglobin synthesis. Common adverse effects include gastrointestinal irritation, nausea, and black stools.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xinxuebao Capsules.